20
Aug
Using genomic analysis to define the molecular causes of symptoms in patients with Chromosome 9 P Minus Syndrome
0 Comment
Using genomic analysis to define the molecular causes of symptoms in patients with Chromosome 9 P Minus Syndrome Research Site: Washington University School of Medicine, St. Louis, Missouri USA The goal of our research project is to identify the specific genes that are deleted in people with 9 P Minus... Read More
20
Aug
CDO’s Summer 2020 Newsletter
CDO’s Summer 2020 Newsletter is now available! Each issue contains detailed and new information on rare chromosome disorders. The CDO newsletter includes family stories, additional resources, Ask the Doctor, new research updates and more. To submit an article, story or other item of interest for an upcoming issue email info@chromodisorder.org... Read More
16
Aug
Population prevalence of copy number variants (CNVs)a first glimpse
Estimates of the population prevalence and inheritance patterns of recurrent copy number variants (CNVs) associated with neurodevelopmental disorders are lacking. This article presents a first glimpse. It is well known that chromosome microdeletions or microduplications in several areas (1q21.1, 3q29, 15q11, 15q13, 16p11.2, etc) are associated with a wide range... Read More
04
Aug
NF1 microdeletions and mutations gene location chromosome 17q11.2
Neurofibromatosis type 1 (NF1) is a hereditary syndrome. The main manifestations of this condition include café-au-lait spots, Lisch nodules and neurofibromas. It occurs in 1 to every 2000-3000 people. In most patients NF1 is caused by mutations of the NF1 gene, located at 17q11.2. However, 5-11% of patients have deletions... Read More
